Viridian Announces Pricing of £540 Million (Equivalent) Notes Offering
Viridian Group FinanceCo PLC and Viridian Power and Energy Holdings DAC (together, the “Issuers”), subsidiaries of Viridian Group Investments Limited (“Viridian”), a portfolio company of I Squared Capital, have priced their offering of £540 million (equivalent) in aggregate principal amount of senior secured notes. This issuance comprises a Euro tranche of €350 million of 4.00 percent senior secured notes due 2025 and a Sterling tranche of £225 million of 4.75 percent senior secured notes due 2024 (together, the “Notes”).
Viridian intends to use the proceeds of the Notes, together with amounts received in relation to the settlement of certain forward foreign exchange contracts and cash on balance sheet, to refinance its existing Euro denominated notes, to pay costs and to pay a £60 million distribution to its shareholders.
The Notes (144A/Reg S) have received a rating of B1 (positive outlook) from Moody’s and an expected BB-(Exp) from Fitch.
“With this refinancing, Viridian is even better positioned to execute its corporate strategy,” said Ian Thom, CEO of Viridian. “The pricing achieved reaffirms the significant improvement in credit quality from growth initiatives, including the commissioning of 168 megawatts of wind capacity in March and April 2017, together with the ongoing construction of a further 75 megawatts of wind capacity. In addition, Viridian continues to hold leading positions across Ireland in a diversified portfolio of assets, including 747 megawatts of thermal generation capacity capable of providing 11 percent of peak demand, over 1.2 gigawatts of power purchase agreements, as well as supplying over 700,000 customers with gas and electricity.”
The offering was led by I Squared Capital in close partnership with the Viridian executive leadership team.
Deutsche Bank, Barclays, and Credit Suisse acted as Joint Global Coordinators and Bookrunners. Lloyds Bank and The Royal Bank of Scotland (trading as NatWest Markets) acted as Bookrunners.
Simpson Thacher & Bartlett LLP acted on behalf of Viridian while Latham & Watkins LLP acted on behalf of the Global Coordinators and Bookrunners.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Viridian
Viridian is a leading integrated Irish energy business with substantial businesses in both Northern Ireland and the Republic of Ireland.
About I Squared Capital
I Squared Capital is an independent global infrastructure investment manager focusing on energy, utilities, telecommunications and transport in the Americas, Europe, and select high growth economies. The Firm has offices in New York, Houston, London, New Delhi, Hong Kong, and Singapore.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170914005461/en/
Contact information
Viridian Group
Alwyn Whitford, +44 (0) 28 9038 3765
alwyn.whitford@viridiangroup.co.uk
or
I
Squared Capital
Andreas Moon, +1 212-339-5339
andreas.moon@isquaredcapital.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)14.5.2025 09:14:00 EEST | Press release
GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is a phase III-ready, potential best-in-class, investigational specialty medicine to treat and prevent progression of steatotic liver disease (SLD). Under the agreement, GSK will pay $1.2 billion upfront, with potential for additional success-based milestone payments totalling $800 million. Efimosfermin is a novel, once-monthly fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), including cirrhosis, and future development in alcohol-related liver disease (ALD), both forms of SLD. Given efimosfermin’s direct antifibrotic mechanism of action and GSK’s dat
Reply Presents “App to the Future”: A New AI-Scape Room Experience Powered by Microsoft AI and Low-Code Solutions14.5.2025 09:05:00 EEST | Press release
Reply, a global systems integrator and technology consulting firm, introduces “App to the Future” an immersive “AI-Scape Room” an immersive escape room experience powered by Microsoft Copilot, Azure AI, and Power Platform, designed to explore the full potential of AI and low-code tools in a unique and engaging way. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513072546/en/ The experience builds on Reply’s AI-Scape Room focused on Microsoft 365 Copilot, offering enhanced challenges and deeper integration of advanced AI tools to help participants better understand how these technologies can drive business transformation. Developed by WM Reply and Valorem Reply, the Reply companies specialised in digital workplace transformation and AI solutions, “App to the Future” invites participants to engage in an interactive experience where they tackle AI-powered challenges using Microsoft’s suite of tools - including Copilot, Azure
Svante Launches World's First Commercial Gigafactory for Carbon Capture & Removal Filters13.5.2025 23:50:00 EEST | Press release
Svante Technologies Inc. (Svante), a global leader in carbon capture and removal technologies, has officially completed the commissioning of its new Centre of Excellence for Carbon Capture and Removal – Redwood manufacturing Facility (Redwood) in Burnaby, British Columbia. This milestone marks the launch of the world's first gigafactory dedicated to producing commercial-scale carbon capture and removal filters designed to trap CO2 directly from industrial emissions and the atmosphere, and with the mindset of high-volume automation and product standardization to lower the manufacturing cost. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513713072/en/ Claude Letourneau, President & CEO, Svante Group opens the Svante Grand Opening 2025 event, "GO25" with a speech about how to move the carbon management industry forward. This two-day event celebrates the commissioning of Svante's gigafactory in Vancouver, BC, Canada, which w
Svante and SAMSUNG E&A Sign Joint Development Agreement to Offer Digitally Enabled Skid-Mounted Modular Carbon Capture Plants13.5.2025 23:46:00 EEST | Press release
Svante Technologies Inc. (Svante) and SAMSUNG E&A announced today that they have signed a joint development agreement to jointly develop a set of standardized skid-mounted modular carbon capture plants based on Svante’s novel VeloxoTherm solid sorbent-based carbon capture filter technology, leveraging SAMSUNG E&A’s advanced digital solutions and modularization capabilities. The agreement was signed during Svante’s Grand Opening Event, which marked the commissioning of its new commercial filter manufacturing facility in Vancouver, Canada. This is the world’s first gigafactory for Svante’s filter technology, capable of producing enough filters to capture 10 million tonnes of CO2 annually. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513282760/en/ Leaders of SAMSUNG E&A and Svante sign a joint development agreement at a private signing ceremony during Svante's Grand Opening Event in Burnaby, BC, Canada. The companies have
AWS and HUMAIN Announce Groundbreaking AI Zone to Accelerate AI Adoption in Saudi Arabia and Globally13.5.2025 19:09:00 EEST | Press release
Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and HUMAIN, Saudi Arabia’s newly created company responsible for driving AI innovation across the Kingdom and globally, today announced plans to invest $5 billion-plus in a strategic partnership to build a groundbreaking “AI Zone” in the Kingdom. This first-of-a-kind AI Zone will bring together multiple innovative capabilities, including dedicated AWS AI infrastructure and servers with world-class semiconductors, UltraCluster networks for faster AI training and inference, AWS services like SageMaker and Bedrock, and AI application services such as Amazon Q to advance Saudi Arabia’s mission to be a world leader in AI. AWS previously announced and is currently building an AWS infrastructure region in Saudi Arabia that will become available in 2026. Amazon is investing US$5.3 billion (approx. 19.88 billion Saudi riyal) in Saudi Arabia to develop this new region for AWS. The new AI Zone announced today is an addit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom